Company
| Legal Name | BRIDGEBIO PHARMA INC |
| Headquarters | Zürich, Switzerland |
| Website | https://bridgebio.com |
BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 20+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs. Our focus on scientific excellence and rapid execution aim to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, and Raleigh, with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zurich, Switzerland, and are expanding across Europe. To learn more about our story and company culture, visit us at https://bridgebio.com
| Country | City | Job Ads |
|---|---|---|
| United States | San Francisco | 107 |
| United States | Felty | 37 |
| United States | Palo Alto | 19 |
| Switzerland | Zug | 6 |
| Canada | Kanata | 5 |
Loading map...
Legal Form: INC
Company Type: Public
Company Size: 501 - 1000
Job Ads found: 174
Job Ads per Month: 5.1
Hiring Locations: 5
| Date of first job ad | 31.08.2021, 00:00 |
| Date of last job ad | 13.02.2026, 13:00 |
| Date merged | 13.02.2026, 22:26 |
| Date created | 31.08.2021, 00:00 |